The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorcros Regulatory News (NXR)

Share Price Information for Norcros (NXR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 183.50
Bid: 181.50
Ask: 185.00
Change: 4.50 (2.51%)
Spread: 3.50 (1.928%)
Open: 189.00
High: 189.00
Low: 181.50
Prev. Close: 179.00
NXR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading update

11 Apr 2024 07:00

RNS Number : 0965K
Norcros PLC
11 April 2024
 

11 April 2024

 

 

Trading update - Underlying operating profit in line with expectations

 

 

Norcros plc ("Norcros" or the "Group"), a market-leading designer and supplier of high quality bathroom and kitchen products in the UK, Europe and South African markets will announce its full year results for the year ended 31 March 20241 on 13 June 2024. In advance of this, the Group is pleased to provide the following trading update.

 

Trading

 

The Group has continued to demonstrate the strength of its business in a challenging demand environment, and the Board expects underlying operating profit for the year ended 31 March 2024 to be in line with market expectations2.

 

Overall Group revenue for the year ended 31 March 2024 is expected to be circa £390 million (2023: £441.0 million), 11.1% below prior year on a reported basis and 6.1% below on a constant currency ("CC") like for like ("LFL3") basis.

 

Revenue versus prior year

Reported

LFL3

UK

(4.7%)

(3.3%)

South Africa

(24.1%)

(24.1%)

South Africa at CC

(12.3%)

(12.3%)

Group

(11.1%)

(10.4%)

Group at CC

(7.0%)

(6.1%)

 

Our market-leading UK business has performed robustly, with revenue 3.3% below prior year on a LFL basis with year on year improvement in operating margins. This improvement has been driven by ongoing portfolio management, our proven new product development programme and our positioning within the more resilient mid-premium segment of the RMI market.

 

Our South African business performed resiliently, despite the challenging market conditions aggravated by the significant and unpredictable power interruptions in H1. Reported revenue for the year was 12.3% lower than prior year on a CC basis. The local management team has implemented proactive self-help initiatives and, notwithstanding improved power availability, we expect the recovery in demand to be gradual.

 

Financial position and extension of banking facilities

 

The Group remains in a strong financial position, maintaining its historically high levels of cash generation, with net debt (on a pre-IFRS 16 basis) at 31 March 2024 expected to be circa £37 million (2023: net debt of £49.9 million). This represents leverage of less than 0.9x underlying EBITDA and provides a solid foundation from which the Group can execute its strategic priorities.

 

Net Zero targets - SBTi approved

We are pleased to announce that the Group's targets for Near Term and Net Zero emission targets have been validated and approved by the Science Based Targets initiative ("SBTi") and we continue to make progress to reduce our emissions. Our approved targets are listed on the Science Based Targets website: https://sciencebasedtargets.org/companies-taking-action

 

Notice of results and capital markets event

 

The Group will announce its full year results for the year ended 31 March 2024 on Thursday 13 June 2024. Ahead of this, there will be a Capital Markets Event on Wednesday 1 May 2024. For further details please contact norcros@hudsonsandler.com.

 

Thomas Willcocks, Chief Executive Officer, said:

 

"Norcros has again demonstrated the strength of its business and leading positions in its end markets, delivering solid results notwithstanding the macroeconomic challenges. The Group's focus on continuing portfolio management, our collective organic growth accelerators and scale-based operational efficiencies will continue to deliver profitable market share growth in the year ahead."

 

 

1. The accounting reference 'year to 31 March 2024' relates to the 52-week period commencing on 3 April 2023 and ending 31 March 2024

2. Norcros-compiled market consensus for the year to 31 March 2024 underlying operating profit is £42.7 million

3. LFL (like for like) adjusted for Grant Westfield (acquired 31 May 2022) and Norcros Adhesives

 

 

 

 

 

Enquiries

Norcros plc

Tel: 01625 547700

Thomas Willcocks, Chief Executive Officer

James Eyre, Chief Financial Officer

Hudson Sandler

Tel: 0207 796 4133

Nick Lyon

Lucy Wollam-Coles

Notes to Editors

Norcros is a market-leading designer and supplier of high quality bathroom and kitchen products in the UK, Europe and South African markets.

In the UK, Norcros operates under seven brands, Triton, Merlyn, Grant Westfield, Vado, Croydex, Abode, and Johnson Tiles.

In South Africa, Norcros operates under four brands, Tile Africa, House of Plumbing, TAL, and Johnson Tiles.

Norcros is headquartered in Wilmslow, Cheshire and employs around 2,300 people. The Company is listed on the London Stock Exchange. For further information please visit the Company website: http://www.norcros.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTQBLFFZZLFBBV
Date   Source Headline
25th Apr 20247:00 amRNSSale of Johnson Tiles UK
22nd Apr 20242:00 pmRNSInvestor Webinar 7 May 2024
12th Apr 20243:40 pmRNSHolding(s) in Company
11th Apr 20247:00 amRNSTrading update
28th Mar 20247:00 amRNSBlock listing Six Monthly Return
28th Mar 20247:00 amRNSVoting Rights and Share Capital Update
1st Mar 20242:09 pmRNSDirectors Share Dealing
23rd Jan 202411:40 amRNSHolding(s) in Company
23rd Jan 20247:00 amRNSAppointment of Joint Corporate Broker
22nd Dec 20237:00 amRNSEmployee SAYE awards and director share dealing
1st Dec 20234:35 pmRNSDirector Declaration
23rd Nov 20234:06 pmRNSDirector/PDMR Shareholding
16th Nov 20237:00 amRNSInterim Results
3rd Nov 20239:00 amRNSInvestor Presentation
12th Oct 20237:00 amRNSTrading Update
1st Sep 20237:00 amRNSBlock Listing Six Monthly Return
11th Aug 20234:36 pmRNSDirector's Dealings
26th Jul 20234:50 pmRNSResults of AGM
26th Jul 20231:06 pmRNSDirector's Dealings
26th Jul 20237:00 amRNSAGM Trading Statement
10th Jul 20235:59 pmRNSDirector's Dealings
23rd Jun 20237:00 amRNSAnnual Financial Report and Notice of 2023 AGM
15th Jun 20237:00 amRNSFinal Results
30th May 20237:00 amRNSDirectorate Changes
13th Apr 20237:00 amRNSTrading Update
31st Mar 20237:00 amRNSTotal Voting Rights
28th Mar 20234:16 pmRNSHolding(s) in Company
21st Mar 20234:35 pmRNSPrice Monitoring Extension
28th Feb 20233:19 pmRNSBlock Listing Six Monthly Return
14th Feb 20237:00 amRNSDirectorate Update
30th Jan 20237:00 amRNSCEO Succession
24th Jan 20237:00 amRNSDirectorate Update
15th Dec 20229:40 amRNSBoard Changes
9th Nov 20227:00 amRNSInterim Results
1st Nov 202212:07 pmRNSHolding(s) in Company
13th Oct 20227:00 amRNSTrading Update
30th Sep 20227:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
30th Sep 20227:00 amRNSVoting Rights and Share Capital Update
13th Sep 20224:35 pmRNSPrice Monitoring Extension
31st Aug 20229:39 amRNSVoting Rights and Share Capital Update
26th Jul 202212:30 pmRNSHolding(s) in Company
25th Jul 20222:23 pmRNSDirectors' Dealings
19th Jul 20222:05 pmRNSResults of AGM
19th Jul 20221:57 pmRNSDirector Dealings
19th Jul 20227:00 amRNSAGM Trading Statement
15th Jul 20225:08 pmRNSVoting Rights and Share Capital Update
30th Jun 20229:08 amRNSVoting Rights and Share Capital Update
21st Jun 20225:21 pmRNSDirector Declaration
16th Jun 202211:16 amRNSNotice of AGM Annual Report Announcement
14th Jun 20222:25 pmRNSHoldings in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.